Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Vaccine|January 27, 2004
Stability of mono- and trivalent meningococcal outer membrane vesicle vaccinesCarmen Arigita, Wim Jiskoot, Janny Westdijk, et al.Journal of Pharmaceutical Sciences|February 3, 2022
Immunochemical and biophysical characterization of inactivated Sabin poliovirus products: Insights into rapid quality assessment toolsJanny Westdijk, Amy Kogelman, Robert van der Put, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2010
Bioneedles as alternative delivery system for hepatitis B vaccineHoang J H B Hirschberg, Gijsbert G P van de Wijdeven, Heleen Kraan, et al.Molecular Pharmaceutics|October 5, 2020
Novel Formaldehyde-Induced Modifications of Lysine Residue Pairs in Peptides and Proteins: Identification and Relevance to Vaccine DevelopmentThomas J M Michiels, Christian Schöneich, Martin R J Hamzink, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 26, 2009
Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulationsSuzanne M Bal, Bram Slütter, Elly van Riet, et al.Vaccine|November 27, 2002
Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidatesKoert J Stittelaar, Helma W Vos, Geert van Amerongen, et al.Plos One|March 28, 2014
Solid bioneedle-delivered influenza vaccines are highly thermostable and induce both humoral and cellular immune responsesPeter C Soema, Geert-Jan Willems, Klaas van Twillert, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 6, 2004
Immunogenicity of meningococcal PorA formulations encapsulated in biodegradable microspheresCarmen Arigita, Joost van den Berg, Karin Wensink, et al.Vaccine|April 15, 2008
Bioneedles as vaccine carriersHoang J H B Hirschberg, Gijsbert G P van de Wijdeven, Annemarie B Kelder, et al.Vaccine|July 5, 2005
Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivativesCarmen Arigita, Thomas Luijkx, Wim Jiskoot, et al.Pageof 5